Basilea - About the company
Basilea is a public company based in Basel (Switzerland), founded in 1999. It operates as a Developer of antibiotics, antifungals, and oncology drugs for treating multiple diseases. Basilea has raised an undisclosed amount in funding. The company has 127 active competitors, including 41 funded and 22 that have exited. Its top competitors include companies like Insmed, Evofem and Affinivax.
Company Details
Developer of antibiotics, antifungals, and oncology drugs for treating multiple diseases. Its product portfolio includes ceftobiprole for pneumonia, isavuconazole for fungal infections, and 3 other pipeline products under development. It also has a leading candidate BAL 101553 for recurrent or progressive glioblastoma.
- Website
- Email ID
- @basilea.com
Key Metrics
Founded Year
1999
Location
Basel, Switzerland
Stage
Public
Latest Funding Round
Investors
Ranked
8th among 127 active competitors
Similar Companies
Insmed &
Exit Details
Public
Legal entities associated with Basilea
Basilea is associated with 1 legal entity given below:
Legal Entity Name | Date of incorporation | Revenue | Net Profit | Employee Count |
---|---|---|---|---|
Jul 09, 2007 | - | 347 | 259 |
Get your free copy of Basilea's company profile
Basilea's funding and investors
Basilea has raised funding over 7 rounds. Its first funding round was on 2001. Its latest funding round was a Grant (prize money) round on Dec 23, 2024 for $7.3M. 1 investor participated in its latest round, which include Athyrium Capital Management, HBM Partners and CARB-X.
Basilea has 3 institutional investors including , HBM Partners and CARB-X.
Here is the list of recent funding rounds of Basilea:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
---|---|---|---|---|---|
Dec 23, 2024 | $7.3M | Grant (prize money) | 2536664 | 8509195 | |
Apr 09, 2024 | $900K | Grant (prize money) | 2725073 | 5794472 | |
Aug 16, 2021 | $4.3M | Grant (prize money) | 9338081 | 5140835 | - |
View details of Basilea's funding rounds and investors
Basilea's Competitors and alternates
Top competitors of Basilea include Insmed, Evofem and Affinivax. Here is the list of Top 10 competitors of Basilea, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
---|---|---|---|---|---|
1st | Insmed 1999, Bridgewater (United States), Public | Developer of small molecule inhibitors for rare lung diseases | - | Hercules Capital, Ridgeback Capital ManagementÌý&²¹³¾±è;Ìý | 69/100 |
2nd | Evofem 2009, San Diego (United States), Acquired | Developer of therapeutics for reproductive care for women | $100M | Woodford Investment Management, PDL BiopharmaÌý&²¹³¾±è;Ìý | 67/100 |
3rd | Affinivax 2013, Cambridge (United States), Acquired | Developer of technology-based conjugate vaccines against infectious diseases | $359M | Foresite Capital, T. Rowe PriceÌý&²¹³¾±è;Ìý | 66/100 |
4th | Imvax 2015, Philadelphia (United States), Series C | Developer of cell vaccines for the treatment of gliomas | $204M | 65/100 | |
5th | Eligo Bioscience 2014, Paris (France), Series B | Developer of microbiome gene therapies against infectious disease | $52.3M | Seventure Partners, Khosla VenturesÌý&²¹³¾±è;Ìý | 64/100 |
6th | Aridis Pharma 2005, San Jose (United States), Public | Provider of human monoclonal antibodies against infectious diseases | $42.1M | , HHSÌý&²¹³¾±è;Ìý | 63/100 |
7th | GT Medical Technologies 2017, Tempe (United States), Series C | Provider of medical devices for radiation therapy for bran tumor treatment | $116M | Gilde Healthcare, HorizonÌý&²¹³¾±è;Ìý | 62/100 |
8th | 1999, Basel (Switzerland), Public | Developer of antibiotics, antifungals, and oncology drugs for treating multiple diseases | - | Athyrium Capital Management, HBM PartnersÌý&²¹³¾±è;Ìý | 52/100 |
9th | MaaT Pharma 2014, Lyon (France), Public | Developer of microbiome therapy for the treatment of intestinal dysbiosis diseases | $42.3M | Seventure Partners, Credit Mutuel EquityÌý&²¹³¾±è;Ìý | 60/100 |
10th | ![]() Lodo Therapeutics 2015, New York City (United States), Acquired | Developer novel therapeutics to treat resistant infectious diseases and cancers using AI | $19.9M | Arch Venture Partners, 180 Degree CapitalÌý&²¹³¾±è;Ìý | 58/100 |
Looking for more details on Basilea's competitors? Click to see the top ones
Basilea's Investments and acquisitions
Basilea has made no investments or acquisitions yet.
Reports related to Basilea
Here is the latest report on Basilea's sector:
View
News related to Basilea
Media has covered Basilea for a total of 29 events in the last 1 year, 16 of them have been about company updates and 3 about partnerships.
•
EuropaWire•Apr 24, 2025•Basilea,
•
•
GlobeNewswire•Apr 16, 2025•Basilea
•
•
GlobeNewswire•Mar 14, 2025•Basilea
•
Seeking Alpha•Feb 18, 2025•Basilea
•
GlobeNewswire•Feb 18, 2025•Basilea
•
DJIB XINWEN•Feb 05, 2025•Basilea
•
EuropaWire•Feb 05, 2025•Basilea,
•
GlobeNewswire•Jan 28, 2025•Basilea
Frequently asked questions about Basilea
When was Basilea founded?
Basilea was founded in 1999.Where is Basilea located?
Basilea is located in Basel, Switzerland.When was the latest funding round of Basilea?
Basilea's latest funding round was on Dec 23, 2024.What is the annual revenue of Basilea?
Annual revenue of Basilea is undefined as on undefined.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies
212K+ Investors
580K+ Funding Rounds
207K+ Acquisitions
2.9K+ Sectors
57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- Heineken Slovensko - Komarno based, 2007 founded, Funding Raised company
- Alcean - Petaling Jaya based, 2005 founded, Seed company
- Relativity Networks - Orlando based, 2023 founded, Seed company
- Helzel Messtechnik - Kaltenkirchen based, 1995 founded, Funding Raised company
- Menoufia University - Cairo based, 1976 founded, Funding Raised company
- Rytstory - Ghaziabad based, 2023 founded, Unfunded company